Sino Biopharmaceutical Ltd. revenue breakdown overview

Sino Biopharmaceutical Ltd. revenue for the last year amounted to 3.69 B USD, the most of which — 3.65 B USD — came from its highest performing source at the moment, Modernised Chinese Medicines and Chemical Medicines, the year earlier bringing 4.20 B USD. The greatest contribution to the revenue figure was made by China — last year it brought Sino Biopharmaceutical Ltd. 3.71 B USD, and the year before that — 4.28 B USD.